See related article at KEY POINTS In Canada, federal, provincial, and territorial governments have embarked on a major effort to improve the interoperability of health data, as indicated by Bill C-72 ...
A healthy 9-year-old boy presented to our dermatology clinic for evaluation of a 2-year history of a bruise-like indurated ...
Jennifer M. Siu, Evan J. Propst and Nikolaus E. Wolter ...
Background: In Canada, many patients face substantial out-of-pocket costs for prescription medication, which may affect their ability to take their medications as prescribed. We sought to conduct a ...
On Oct. 10, 2024, Bill C-64 — comprising the first concrete measures to implement universal, single-payer, public pharmacare in Canada — became law.1 As an initial step toward full national pharmacare ...
Glucagon-like peptide-1 (GLP-1) receptor agonists (also called “glutides”) are an effective treatment for patients with type 2 diabetes and chronic kidney disease In a randomized controlled trial of ...
Self-reflection on attitudes and beliefs may mitigate bias and discrimination. Structural changes — for which funding is sometimes available — can ensure universal accessibility. Equitable access to ...
Orthostatic hypotension is a key distinguisher between presentations of steroid-induced adrenal insufficiency and HIV-related lipodystrophy. In patients taking cobicistat-containing antiretroviral ...
Five Things to Know About ...: Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes ...
Malgré sa connotation historique, le scorbut (hypovitaminose C) doit faire partie du diagnostic différentiel chez les personnes qui présentent des saignements anormaux. L’hypovitaminose C peut souvent ...